Emery Minnard
Surgical Oncology · Gretna, LANPI 1790887677
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $142,015 of the $182,562 with a category attached, or 77.8%. Evologics LLC accounts for 72.7% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $75,982, 8.6 times the $8,808 reported in 2019. Among surgical oncology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 268 payments — averaging $681.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evologics LLC$133K
- Triad Life Sciences Inc.$17K
- Intuitive Surgical$7K
- Pacira Pharmaceuticals Incorporated$5K
- Biom'up SA$5K
- Convatec Inc.$3K
- plus $12K from 21 others
What the payments were for
- Consulting fees$142,01578%
- Travel & lodging$6,0633%
- Food & beverage$11,9287%
- Education$5,5003%
- Other$17,0579%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evologics LLC | 2 | $132,800 |
| Triad Life Sciences Inc. | 7 | $17,273 |
| Intuitive Surgical | 15 | $6,680 |
| Pacira Pharmaceuticals Incorporated | 18 | $5,199 |
| Biom'up SA | 16 | $5,051 |
| Convatec Inc. | 4 | $3,240 |
| AbbVie(2 entities) | 92 | $2,814 |
| Johnson & Johnson(2 entities) | 41 | $2,165 |
| Biom'up France SAS | 14 | $1,636 |
| Stryker | 6 | $1,617 |
| Medtronic(2 entities) | 15 | $882 |
| Medical Device Business Services, Inc. | 6 | $762 |
| Mimedx Group, Inc. | 5 | $647 |
| Covidien LP | 6 | $406 |
| Dilon Technologies, Inc. | 2 | $268 |
| Boston Scientific | 7 | $176 |
| Sientra, Inc. | 1 | $173 |
| Angiodynamics, Inc. | 1 | $161 |
| Bard Peripheral Vascular, Inc. | 2 | $136 |
| Integra Lifesciences Corporation | 1 | $124 |
| Kerecis Limited | 1 | $98 |
| Davol Inc. | 1 | $96 |
| Baxter Healthcare | 1 | $86 |
| BD | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Innocoll Pharmaceuticals Limited | 1 | $17 |
| Asensus Surgical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$5,500
- EXPAREL$4,837
- HEMOBLAST$4,672
- InnovaMatrix AC$3,079
- HemoBlast Bellows$1,839
- 1588 HD 3 CHIP CAMERA$1,430
- Da Vinci Surgical System$929
- PlasmaBlade$608
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$430
- VISTASEAL$231
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$173
- Nanoknife$161
- Situate$140
- Megadyne$132
- STRATTICE$131
- NONE$125
- SURGICEL Family of Absorbable Hemostats$125
- BIOFIX$124
- BIODRESTORE$124
- BIODFACTOR$124
How this compares
$182,562 in reported general payments places this provider in the 95th percentile of 26 surgical oncology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Megestrol Acetate | 14 | $226 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Gretna
- Mary Hobbs-MaluccioMetairie$41K
- Terry LairmoreShreveport$13K
- Peter BostickBaton Rouge$7K
- Nathan BoltonNew Orleans$6K
- Lindsey FauveauBaton Rouge$4K
- Shawn McKinneyNew Orleans$4K
- David PointerNew Orleans$4K
- Amy RivereNew Orleans$4K
- Omeed MoavenNew Orleans$3K
- Nicole WalkerNew Orleans$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.